Which code goes on an ASC implant line

No single HCPCS code is right for every ASC implant line. Medicare wants no separate implant line at all unless the device has pass-through status. Commercial payers that pay implants separately each set their own rules: which HCPCS code, which claim form, and whether revenue code 0278 sits beside it. None of those rules lets a payer read the device off the code.

What an implant claim needs behind it covers the documents a payer can ask for. This post covers the line itself, read out of the October 2026 HCPCS file, the October 2026 ASC payment addenda, Chapter 14 of the Medicare Claims Processing Manual, five commercial payers’ published policies, and two Texas workers’ compensation fee dispute decisions.

None of them governs your commercial contract, and each payer policy governs only that payer’s own claims. They are useful because they disagree, and every disagreement is a coding decision your biller makes on every implant line.

What do the common ASC implant HCPCS codes say?

Here are nine HCPCS codes that describe orthopedic and soft-tissue implants, with the descriptors exactly as CMS publishes them in the October 2026 HCPCS file, and the payment indicator each one carries in the October 2026 ASC addenda.

Common implant HCPCS codes, October 2026

Code	CMS descriptor	Medicare ASC payment indicator
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	N1, packaged
C1741	Anchor/screw for bone fixation, absorbable, metallic (implantable)	J7, pass-through, contractor-priced
C1734	Orthopedic/device/drug matrix for opposing bone-to-bone or soft tissue-to bone (implantable)	N1, packaged
C1776	Joint device (implantable)	N1, packaged
C1762	Connective tissue, human (includes fascia lata)	N1, packaged
C1763	Connective tissue, non-human (includes synthetic)	N1, packaged
L8641	Metatarsal joint implant	N1, packaged
C1889	Implantable/insertable device, not otherwise classified	N1, packaged
L8699	Prosthetic implant, not otherwise specified	N1, packaged

Two things stand out in the table.

The first is where the C-codes come from. In the HCPCS file each C-code above cites section 1833(t) of the Social Security Act as its statute, and section 1833(t) is the prospective payment system for hospital outpatient department services. That ties the C-codes to hospital outpatient payment. Whether a commercial payer takes them on an ASC claim is that payer’s decision, and the sections below show payers deciding differently.

The second is what a descriptor contains. It names a kind of device and, sometimes, a use. It names no manufacturer, no catalog number and no price. A titanium suture anchor and a different company’s bone-to-bone screw both fit the C1713 descriptor, at whatever each one cost. A HCPCS code tells the payer what kind of device was used. It does not say which device, whose, or what it cost. Everything a carve-out pays on lives somewhere else.

Does Medicare want an implant line on an ASC claim?

Usually not, and the claim it does want is a different form from the one several commercial payers below ask for.

Chapter 14 of the Medicare Claims Processing Manual has ASCs bill Medicare on the professional claim: its claim section is headed “ASC Procedures for Completing the ASC X12 837 Professional Claim Format or the Form CMS-1500.” On that claim, section 40 says implants without pass-through status get no line of their own: “ASCs should not report separate line-item HCPCS codes or charges for items that are packaged into payment for covered surgical procedures and therefore, are not paid separately (e.g., nonpass-through implantable devices). Instead, it is important that ASCs incorporate charges for packaged services into the charges reported for the separately payable services with which they are provided.”

That is what N1 in the table means in practice. C1713, C1776, C1889 and L8699 are all packaged for Medicare in an ASC. The exception is a device with pass-through status, such as C1741 in the table, which Medicare pays separately on the contractor’s pricing. What the CMS manual actually says about ASC implant billing covers the packaging rule, its denial codes and the pass-through exception in full.

So the habits a Medicare claim teaches are no implant line, no implant code and a professional claim format. On a commercial claim that pays the implant separately, each of those can be the wrong habit.

Which claim form does a commercial payer want?

The five commercial policies below lean toward the UB-04, and not all of them in the same words.

• UnitedHealthcare applies its facility device and implant policy, 2026R5019G, to “services reported using the UB04 claim form or its electronic equivalent or its successor form,” and names ASCs among the facilities it covers.
• Blue Shield of California publishes an ASC implant itemization form whose exception payment provision “requires ASCs to submit implant billings on a properly completed UB-04 claim form and on this Implant Itemization Form.”
• Blue Cross and Blue Shield of Vermont, in its claims editing policy CPP_32 (the version effective January 1, 2027), edits ASC claims “submitted with an ASC bill type (083x) and Place of Service 24.” The same policy denies “claim lines reporting C Codes (may include device categories, new technology procedures, and drugs, biologicals and radiopharmaceuticals).) billed on claim type P (Professional).” Read together, which is our reading, a C1713 that would sit on a professional claim at another payer is denied on one at this payer.
• Blue Cross of Idaho, in PAP260 (revised November 2025), accepts either form. It tells ASCs where the implant description goes on each: “field 19 of the CMS-1500 form or field 80 of a UB-04 form.”
• Blue Cross and Blue Shield of New Mexico, in RP007, writes its implant invoice rules around revenue code 0278. Revenue codes are a UB-04 element, so we read that policy as written for UB-04 claims.

Set beside Medicare’s professional claim, that means the claim form is a decision made per payer, not once per facility.

Does revenue code 0278 need a HCPCS code beside it?

At the two payers that say so, yes, and not just any HCPCS code.

UnitedHealthcare: “When a revenue code representing implants is submitted, a HCPCS code which meets the FDA definition of an implant must be reported for outpatient services. If a HCPCS code is not submitted or if the HCPCS code submitted does not match the FDA definition of an implant, the claim line with the implant revenue code will not be reimbursed.” One scope note, in the policy’s own terms: its implant section says it “will be applied to inpatient and outpatient hospital services,” while its application section names ASCs, so we read it as reaching ASC claims on the UB04. Its Q and A answers the obvious question directly: “A HCPCS code must be submitted with revenue code 0278 for outpatient claims. If an appropriate HCPCS code is not submitted, the line item will be denied.”

The policy then lists ten “Examples of HCPCS That Do Not Meet the FDA Definition of an Implant”: C1724, C1725, C1726, C1727, C1732, C1753, C1754, C1757, C1758 and C1759. Every one of them is a catheter in the HCPCS file. The list is labelled as examples, so it is not the whole set. The point it makes is that a C-code is not an implant code just because it is a device code.

Blue Cross VT runs the same check from the other side. Citing the UB-04 data specifications, its policy says “certain revenue codes require an appropriate HCPCS code to be billed on the same line. Furthermore, claim lines billed with HCPCS are required to match the revenue codes reported or the service is denied,” and lists 0278 (Other implants) as one of them.

Specific code, or L8699 and C1889?

The unspecified codes look like the safe choice, because every implant fits “not otherwise specified.” Blue Cross of Idaho’s policy is the clearest statement of why they are not.

• “Any unspecified code with a charge over $1,000 requires an approved authorization to be eligible for consideration.”
• Unspecified codes “must be billed with a complete description of the implant or device,” in field 19 of the CMS-1500, field 80 of the UB-04, or the remarks field on an electronic claim.
• “If Blue Cross of Idaho determines more appropriate coding is available even though billed under L8699, C1889 or other unspecified implant codes, a corrected claim will be required.”
• “Each implant or device must be billed on a separate claim line with the appropriate Healthcare Common Procedure Coding System (HCPCS) code.”
• “Surgical implements, such as but not limited to sutures, staples, wire, clips and other supplies, are not separately reimbursable and should not be billed using unspecified implant codes.”

The same policy sets the price rule for ASCs: implants with an invoice cost of $100 or less are included in the procedure allowance, those above it are reimbursed “at invoice cost, including shipping and handling, less any rebates or discounts,” and “Billed charges for implants and implantable devices must be the invoice cost.” Read plainly, that last sentence means the charge on the line has to be built from the invoice.

That is one payer, in one state. It is still a useful model, because it spells out what the unspecified codes cost: an authorization, a written description, and the risk of rebilling the line.

One line per implant, or units?

Payers ask for this differently too.

Blue Cross of Idaho wants each implant “on a separate claim line.” Blue Cross and Blue Shield of New Mexico counts units against the invoice: “If the units do not match or are not noted, the revenue code 0278 will be denied, unless otherwise agreed upon,” and on a bulk purchase “the units that apply to the claim billed must be noted on the invoice.” Blue Shield of California’s itemization form puts both sides on one page: for each implant, the line number on the claim, the CPT or HCPCS code, the revenue code, the units and the billed amount, set against the manufacturer’s invoice, and “The item and units matching the implant must be included in the detail itemization.”

Notice what that form is. It is a table whose only job is to connect a claim line to an invoice line. A payer that pays on invoice cost needs that connection, and the code alone cannot carry it.

The code names a category. The invoice names the device.

Two decisions from the Texas Division of Workers’ Compensation show what happens when that connection is missing. Both are 2019 medical fee disputes between an ASC and a workers’ comp carrier under the Texas ASC fee guideline, 28 TAC 134.402. For a separately reimbursed implant, that rule pays the lesser of the manufacturer’s invoice amount or the net amount (exclusive of rebates and discounts), plus an add-on of 10 percent or $1,000 per billed item, whichever is less, capped at $2,000 in add-ons per admission. Both involved the same two codes, C1713 and L8699.

In the first, a rotator cuff case (CPT 29827, 29824 and 29826), the ASC asked for $661.20 more on its C1713 and L8699 lines. It submitted invoices from four vendors: CPM Medical Consultants, Arthrex, Zimmer Biomet and Valeris Medical. The division found: “The requestor did not submit an implant record or a list to identify which implantables on these invoices corresponded to HCPCS codes C1713 and L8699; therefore, additional reimbursement cannot be recommended.” It ordered $0.00.

In the second, an ankle and foot case, the ASC asked for $3,634.35 more on the same two codes. This time the division “reviewed the submitted Implant Record and invoice from Arthrex,” listed each Arthrex product code against its HCPCS code, priced each at cost plus 10 percent, and ordered $3,060.60. The decision also shows the problem at small scale: in that dispute the C1713 code covered two different Arthrex products, a pair of suture anchors and an InternalBrace implant system, at different prices.

• No implant record linking invoices to codes$0.00 of $661.20
• Implant record listing each product code against its HCPCS code$3,060.60 of $3,634.35

Amounts from Texas DWC decisions M4-19-5150-01 and M4-19-4335-01. Bar length is our calculation of the share of each disputed amount that was ordered paid, out of 100%: 0% and 84%.

The second decision did not turn on that alone: the division also set aside a defence the carrier raised too late and a negotiated discount it found no contract for. But the first decision turned on nothing else. Same codes, same fee rule, same agency. What decided the first case was the absence of a record saying which invoice line belonged to which code.

These are workers’ comp decisions in one state. We read the lesson as general all the same: any contract that pays an implant on invoice cost needs the claim line and the invoice line tied together, and the HCPCS code is the one element on the claim that cannot do the tying.

A checklist for every implant line

Drawn from the sources above, with the last item marked as ours because no rule above asks for it.

1. Know which claim form each payer wants for ASC facility claims. Medicare takes the 837 professional format; several commercial payers want the UB-04.
2. For Medicare, give a packaged (N1) implant no line of its own. Fold its charge into the procedure line. Pass-through devices (J7) are the exception.
3. On a UB-04, put a HCPCS code beside revenue code 0278, and one the payer accepts as an implant, not just any device code.
4. Use the most specific code that describes the device. Where L8699 or C1889 is the only fit, add a complete description and check the payer’s authorization threshold first.
5. Bill one line per implant or units per line, as the payer asks, and make the units agree with the invoice.
6. Keep an implant record that ties every implant line to its invoice line: product code, HCPCS code, units and cost.
7. Ours, not theirs: once a month, check every implant on the vendor invoices against the claims that went out. None of the six above finds an implant line that was never created.

Where Bill-Back fits

Item seven is the product, so treat this section as the vendor pitch it is. One thing up front: Bill-Back does not choose HCPCS codes. That stays with your coder and your biller, and nothing below changes it.

Bill-Back reads three documents a center already has: the monthly case log export from the PMS, the vendor invoice PDFs, and the Paid Claims Report, which shows which implant lines were already billed. Your file is read in your browser, and only what the audit needs is sent: procedure month, payer, CPT code, procedure description, surgeon name, and supply notes, plus a hashed case reference if you map one. Supply notes are sent as the nurse wrote them, because the device description and catalog number are what the audit matches on. Everything sent is handled under a signed BAA.

Each supply note is matched to a vendor catalog number and priced at your contracted rate. Then someone on your side clears anything already on a claim, which is the step that separates matched value from recoverable dollars. What survives becomes a payer-ready Recoup Packet: the corrected claim, the reimbursement basis quoted from your own contract, and the matched invoice line as Exhibit A, for your own biller to code and submit. A corrected claim inside the filing window, not an appeal. In our reading, Exhibit A is the same link the first Texas decision found missing: this case, this invoice line.

Commercial payers, plus workers’ comp through manual review. Not Medicare, for the reason in the Medicare section. Stryker and Arthrex invoices are supported today, everything else goes through manual review, and new invoice layouts are added as centers send their invoices. Free to audit, and you only pay when the payer pays.

You can estimate what that seam is worth at your case volume in about thirty seconds, or start a free audit against a month of your own files.

Sources

Government and regulatory

• Alpha-Numeric HCPCS File, October 2026, CMS HCPCS quarterly update. Long descriptors, pricing indicators and statute citations for every code in the table.
• October 2026 ASC Approved HCPCS Code and Payment Rates, CMS. Addendum BB payment indicators, and Addendum DD1 for the definitions of N1 and J7.
• Medicare Claims Processing Manual, Chapter 14: Ambulatory Surgical Centers, CMS (Rev. 13836, issued June 24, 2026). The claim format and the instruction not to report packaged implants as separate lines.
• 42 U.S.C. 1395l(t), section 1833(t) of the Social Security Act, “Prospective payment system for hospital outpatient department services,” via Cornell LII.
• Medical Fee Dispute Resolution Findings and Decision, M4-19-5150-01, Texas Department of Insurance, Division of Workers’ Compensation (September 11, 2019).
• Medical Fee Dispute Resolution Findings and Decision, M4-19-4335-01, Texas Department of Insurance, Division of Workers’ Compensation (July 3, 2019).

Payer policies

• Device, Implant, and Skin Substitute Policy, Facility, UnitedHealthcare Commercial and Individual Exchange reimbursement policy 2026R5019G (version dated October 18, 2026).
• PAP260, Implantable Device Audit and Billing Procedure, Blue Cross of Idaho provider administrative policy (revised November 2025).
• Ambulatory Surgical Center Implant Itemization Form, Blue Shield of California, listed on its patient care forms page.
• Payment Policy CPP_32, Claims Editing, Blue Cross and Blue Shield of Vermont (last reviewed October 1, 2026, effective January 1, 2027).
• Implant, Device, and Tissue Policy, RP007, Blue Cross and Blue Shield of New Mexico (effective August 28, 2026).